News

Neurotrope, Inc. announced positive top-line results from its Phase 2 study (-202 Study) of Bryostatin-1 in patients with moderate to severe Alzheimer's disease (AD), a population not…
Read More...

GSK announced $139 million of new investment in its biopharmaceutical manufacturing site in Rockville, MD to support growing demand for BENLYSTA® (belimumab) for adult patients with…
Read More...

Shire plc and Parion Sciences, Inc. announced they have entered into an agreement granting Shire exclusive worldwide rights to develop and commercialize P-321. Shire will lead…
Read More...

Agreement to buy F-Star Alpha and its lone asset, FS102 between Bristol-Myers Squibb and F-star Alpha has been terminated. Bristol-Myers Squibb and F-star Alpha, entered into an…
Read More...

Sorrento Therapeutics announced that it has successfully completed the transaction for acquisition of Virttu Biologics. In consideration for the acquisition, Virttu equity holders…
Read More...

TAPIMMUNE announced that Dr. Wilson has been appointed President after Dr.John Bonfiglio’s resigned as Chief Operating Officer, President and director of TapImmune Inc. to pursue other…
Read More...

The U.S. FDA approved Rydapt (midostaurin) in combination with Chemotherapy for the treatment of adult patients with newly diagnosed AML (acute myeloid leukemia) who have a specific…
Read More...

MedMira has received CE mark on its syphilis/HIV rapid test, Multiplo TP/HIV, this approval allows company to market and distribute the multiplex rapid test throughout the European…
Read More...

Allergan announced that it has completed the acquisition of ZELTIQ Aesthetics for $2.4 billion cash. ZELTIQ stockholders approved the transaction during the meeting held on April 27,…
Read More...

enGene announced that Theresa Podrebarac, has been appointed as the  Chief Medical Officer of the company. He will be responsible for designing and executing clinical development plan…
Read More...

The US Food and Drug Administration (FDA) has granted Breakthrough Therapy designation to Pfizer’s lorlatinib for the treatment of patients with anaplastic lymphoma kinase…
Read More...

Takeda Pharmaceutical has entered into a multi-year partnership with Harrington Discovery Institute at University Hospitals in Cleveland, Ohio to advance the development of rare disease…
Read More...

TESARO an oncology-focused biopharmaceutical company, announced that following the recent identification of a fixed dose and patient-centric dosing schedule, the ongoing clinical trial…
Read More...

Pharma Major Lupin Limited (Lupin) announced today that it has received final approval for its Olmesartan Medoxomil tablets, 5 mg, 20 mg and 40 mg from the United States Food and Drug…
Read More...

Amcor, a global leader in responsible packaging solutions, will showcase some of its latest packaging solutions for food and beverage, home and personal care, medical and pharmaceutical…
Read More...

XTL Biopharmaceuticals announced that Mr. Alex Rabinovich has been appointed as a member of the Company's board of directors. Mr. Rabinovich is a leading investor in XTL and holds over…
Read More...

Array BioPharma announced that Shalini Sharp, Chief Financial Officer and Executive Vice President of Ultragenyx Pharmaceutical Inc., joined the company's Board of Directors, effective…
Read More...

Merck announced the divestment of its Biosimilars business to Fresenius. The decision to divest Biosimilars is aligned with Merck’s strategy for its Healthcare business sector to focus…
Read More...

The U.S. Food and Drug Administration today approved Brineura (cerliponase alfa) as a treatment for a specific form of Batten disease. Brineura is the first FDA-approved treatment to…
Read More...

MEDITE Cancer Diagnostics specializing in the development, manufacturing and marketing of molecular biomarkers and premium medical devices for detection, risk assessment and diagnosis…
Read More...